Meet us at ISSCR 2024, July 10–13

We look forward to meeting you at ISSCR 2024, July 10–13 in Hamburg, Germany.

Meet Susanne Gröndahl, Senior Key Account Manager, Camille Fournier-Sandberg. Marketing Communications Specialist, Dr. Therése Kallur, CSO of VP Business Development, Dr. Malin Kele, Director of Development, and Dr. Evan Graham, Business Development Manager.

We have planned so much for you, here is a sneak peek:

– Meet our team at booth#903. We would love to learn more about your research and discuss how our full-length Biolaminin® matrices can support your cell culture.

– Attend our poster presentations:

  • Poster #269: “Gene editing cells using CRISPR-Cas9 on Biolaminin® 521 improves single-cell survival and cloning, enabling consecutive differentiation of human pluripotent stem cells on biorelevant matrices”
    Thursday, July 11 from 3:45 to 4:45
  • Poster #254: “Organ-specific expression data steer choice of laminin proteins for in vitro studies, for biologically relevant drug discovery and development platforms”
    Thursday, July 11 from 4:45 to 5:45
  • Poster #363: “Full-length laminins are crucial for recreating the cellular niche in vitro“
    Friday, July 12 from 3:45 to 4:45
  • Poster #408: “Recombinant laminin proteins provide a biologically relevant niche for primary cells in vitro, mimicking the natural niche for both adult stem cells and cancer cells”
    Friday, July 12 from 4:45 to 5:45

Join us at our innovation showcase on Thursday, July 11 from 6 pm: “Biolaminin® technology: supporting standardization for translational success”.

Our invited speakers, Dr. Hawkins, CTO of Pluristyx Inc., and Dr. Gaskell, CTO of Rinri Therapeutics Ltd., will share their stories of translation success. Dr. Ilse Eidhof from Lund University/ Karolinska Institute will share how defined culture conditions robustly maintain human stem cell pluripotency via tightly controlled Ca2+ signaling.

Refreshments will be provided and one lucky attendee will have their name drawn to win a gift card.

Pre-register now

Stay tuned, more information will soon be provided!

See you soon! Bis bald!